Notice names this product. Aurobindo Pharma USA’s Dicyclomine Hydrochloride Capsules is named in FDA Class II recall D-0733-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: shortfill; reports of empty capsules. Identifying details: Batch # DMC125018A, Exp Date: 07/2027.. Units affected: 6,408 bottles distributed to market. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
shortfill; reports of empty capsules.
Company / brand: Aurobindo Pharma USA
Affected product: Dicyclomine Hydrochloride Capsules
Official ID D-0733-2026 · Official record ↗
See all Aurobindo Pharma USA recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.